Benarous, Isabelle – Trademark Portfolio

Entity Type: 01

Benarous, Isabelle holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BIO-NLP and BIOREPROGRAMMING. The owner is based in Altadena, CA.

po box 6258

Altadena, CA 91003

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Benarous, Isabelle's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (5 filings)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Benarous, Isabelle have?

Benarous, Isabelle has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.

What trademark classes does Benarous, Isabelle file in?

Benarous, Isabelle files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Benarous, Isabelle's most well-known trademarks?

Benarous, Isabelle's registered trademark portfolio includes well-known marks such as BIO-NLP and BIOREPROGRAMMING. These are among 2 currently registered trademarks in the portfolio.

What is Benarous, Isabelle's trademark registration success rate?

Benarous, Isabelle has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.